U.S. Bowel Management Systems Market Revenue & Forecast Analysis, 2026-2035

The U.S. bowel management systems market size was estimated at USD 644.78 million in 2025. The market is expected to grow at a CAGR of 3.9% from USD 665.86 million in 2026 to USD 937.08 million in 2035. The strong market growth is propelled by the increasing occurrence of fecal incontinence and bowel issues, an elderly demographic, a higher rate of neurological and gastrointestinal conditions, an enhanced emphasis on infection control, and a need for solutions that lessen caregiver burdens.

Published: August 25, 2026
100 Pages

Market Overview

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) states that issues with bowel control impact millions of Americans and grow more prevalent as people age, resulting in a significant demand for effective fecal management and bowel care options.

The U.S. bowel management systems market has shown steady historical growth, driven by the rising prevalence of fecal incontinence, neurogenic bowel dysfunction, and other issues that impair normal bowel control. Increasing need for efficient bowel-care options in hospitals, long-term care facilities, and home-care environments has prompted broader use of fecal management, bowel irrigation, ostomy, and related systems. For instance, in 2022, Medtronic persisted in broadening its range of therapies for individuals with bowel and pelvic-floor issues, aiding the wider transition to technology-supported management of chronic bowel disorders.

The U.S. bowel management systems market is projected to sustain favourable growth throughout the forecast period due to an ageing population and healthcare providers' heightened focus on patient hygiene, complication prevention, caregiver effectiveness, and overall quality of life. The growing use of minimally invasive and digitally enhanced solutions, along with a greater inclination toward home-based bowel management, is anticipated to create more opportunities for producers. For instance, in 2024, Coloplast maintained its efforts to introduce and enhance patient-focused ostomy and bowel-care solutions aimed at increasing comfort, usability, and independence, aiding the continued development of bowel management in the U.S.

U.S. Bowel Management Systems Market Overview

Base Year Market Size (2025): USD 644.78 Million

CAGR: 3.9%

Forecast Year Market Size (2035): USD 937.08 Million

Major Players:

Becton, Dickinson and Company (BD)

Cardinal Health, Inc.

Coloplast Corp.

ConvaTec Group plc

Hollister Incorporated

U.S. Bowel Management Systems Market Trend

The U.S. bowel management systems market is experiencing significant progress, fueled by rising use of transanal irrigation, creation of user-friendly bowel-care devices, heightened application of technology-driven solutions, and a growing focus on personalized and home-based bowel management.

· A significant trend is the rising use of sophisticated transanal irrigation systems, designed to offer patients with neurogenic bowel dysfunction, chronic constipation, and fecal incontinence a more regulated and convenient method of bowel evacuation.

· The market is witnessing an increasing need for user-friendly and compact bowel management devices, especially those that make setup and administration easier. Producers are concentrating on more compact, user-friendly options that enhance patient autonomy and facilitate use beyond conventional healthcare environments.

· A growing trend is emerging in home-based bowel management, as patients and caregivers are progressively looking for convenient solutions that can be utilized away from hospitals and long-term care centers. This promotes the creation of portable irrigation systems, simplified ostomy products, and various self-management solutions.

· Changes in reimbursement and coding are also impacting the U.S. market. In 2025, CMS updated HCPCS coding for manual transanal irrigation systems, and electronic transanal irrigation systems were assigned a dedicated coding pathway starting in April 2026, facilitating improved reimbursement processes for advanced bowel-care technologies.

· Additionally, increasing interest in minimally invasive nerve modulation and neurostimulation is broadening the treatment options beyond standard containment and irrigation products, especially for individuals suffering from chronic bowel dysfunction and fecal incontinence.

Collectively, the growing use of advanced transanal irrigation, portable and patient-focused devices, home-based bowel care, changing reimbursement options, and technology-driven management solutions are significant trends influencing the U.S. bowel management systems market.

U.S. Bowel Management Systems Market Analysis

By Product Type

Colostomy bags dominate the U.S. bowel management systems market due to their widespread use in patients requiring long-term fecal diversion and the established adoption of ostomy care products.

Based on product type, the U.S. bowel management systems market is categorised into colostomy bags, irrigation systems, nerve modulation devices, and others. The colostomy bags segment holds the largest market share in 2025, accounting for 45.31% in 2025.

By Patient Category

Adults dominate the U.S. bowel management systems market due to the substantial prevalence of fecal incontinence and bowel dysfunction across the adult population and the broad use of bowel management solutions for chronic and postoperative conditions.

Based on patient category, the U.S. bowel management systems market is categorized into pediatric, adults, and elders. The adults segment holds the largest market share in 2025.

By End-use

Hospitals dominate the U.S. bowel management systems market due to their high patient volumes, availability of specialized healthcare professionals, and ability to manage complex bowel dysfunction and postoperative cases.

Based on end-use, the U.S. bowel management systems market is categorized into hospitals, ambulatory surgical centers (ASCs), and home care. The hospitals segment holds the largest market share in 2025.

Key Companies Profiled

The U.S. bowel management systems market is moderately consolidated, with established medical device companies and specialized continence-care manufacturers competing across ostomy products, fecal management systems, bowel irrigation solutions, and neuromodulation technologies. Competition is mainly determined by product effectiveness, patient comfort, skin safeguarding, clinical results, healthcare-provider connections, and distribution coverage. Coloplast, ConvaTec, Hollister, BD, and Medtronic are key players with strong footholds in important categories of bowel and continence care products.

The competitive environment is increasingly influenced by cutting-edge ostomy products, transanal irrigation, automated fecal management, neuromodulation, and home-care solutions focused on patients. Businesses are concentrating on enhancing leakage prevention, skin wellness, comfort, user-friendliness, and patient autonomy while advancing digital and technology-driven bowel-care options. Strategic alliances, innovative products, clinical data, and healthcare purchasing contracts are forecasted to continue being vital strategies for enhancing market presence in the U.S.

U.S. Bowel Management Systems Market Companies:

  • ABC Medical Supply Inc.

  • Axonics, Inc.

  • B. Braun Melsungen AG

  • Becton, Dickinson and Company (BD)

  • Cardinal Health, Inc.

  • Coloplast Corp.

  • ConvaTec Group plc

  • Dentsply Sirona

  • Hollister Incorporated

  • Laborie Medical Technologies

  • Medtronic plc

  • ProSys International Ltd.

  • Qufora A/S

  • Renew Medical Inc.

  • Wellspect Healthcare

  • Welland Medical Limited

Market Segmentation

This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the U.S. Bowel Management Systems market by-

Product Type (Revenue in USD Million, 2021 - 2035)

  • Colostomy Bags

  • Irrigation Systems

  • Nerve Modulation Devices

  • Others

Patient Category (Revenue in USD Million, 2021 - 2035)

  • Pediatric

  • Adults

End-use (Revenue in USD Million, 2021 – 2035)

  • Hospitals

  • Ambulatory Surgical Centers (ASCs)

  • Home Care

Table of Content

1. Methodology and Scope

1.1. Scope of the Study

1.1.1. Market Segmentation

1.1.2. Market Definition

1.1.3. Inclusions and Exclusions of the Study

1.2. Research Design

1.2.1. Base Year, Historical Data, and Forecast Period

1.2.2. Data Collection Methods

1.2.2.1. Secondary Sources

1.2.2.2. Primary Sources

1.2.3. Research Methodology

1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)

1.2.3.2. Volume-Price Approach (Bottom-up Approach)

1.2.3.3. Data Triangulation

1.2.4. Forecasting Model

1.3. Research Assumptions

1.4. Validation and Data Quality Control

1.5. List of Primary Sources

1.6. List of Secondary Sources

2. Executive Summary

2.1. Market Overview

2.2. Segment Snapshot

2.3. Competitive Landscape Snapshot

3. Industry Outlook

3.1. Industry Ecosystem Analysis

3.2. Parent/ Ancillary Market Analysis

3.3. Market Dynamics

3.3.1. Drivers

3.3.2. Restraints/ Challenges

3.3.3. Opportunities

3.4. Value Chain Analysis

3.5. Technology Roadmap

3.6. Porters Analysis

3.7. PESTLE Analysis

4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)

4.1. Colostomy Bags

4.2. Irrigation Systems

4.3. Nerve Modulation Devices

4.4. Others

5. Market Estimates and Forecasts, By Patient Category, 2021 – 2035 (USD Mn)

5.1. Pediatric

5.2. Adults

5.3. Elders

6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)

6.1. Hospitals

6.2. Ambulatory Surgical Centers (ASCs)

6.3. Home Care

7. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)

7.1.1. U.S.

7.1.1.1. U.S. Bowel Management Systems Market Estimates and Forecasts to 2035 (USD Mn)

7.1.1.2. Market Dynamics

7.1.1.3. Competitive Landscape

7.1.1.4. Regulatory Framework

7.1.1.5. Reimbursement Scenario

8. Competitive Landscape

8.1. Company Market Share Analysis, 2025

8.2. Company Tier Structure

8.3. List of Major Suppliers, By Key Countries

8.4. Key Company Positioning Analysis

8.5. Company Profile

8.5.1. ABC Medical Supply Inc.

8.5.2. Axonics, Inc.

8.5.3. B. Braun Melsungen AG

8.5.4. Becton, Dickinson and Company (BD)

8.5.5. Cardinal Health, Inc.

8.5.6. Coloplast Corp.

8.5.7. ConvaTec Group plc

8.5.8. Dentsply Sirona

8.5.9. Hollister Incorporated

8.5.10. Laborie Medical Technologies

8.5.11. Medtronic plc

8.5.12. ProSys International Ltd.

8.5.13. Qufora A/S

8.5.14. Renew Medical Inc.

8.5.15. Wellspect Healthcare

8.5.16. Welland Medical Limited

9. Analyst Perspective

10. Related Reports

Revolution Insights Briefs

Stay informed with updates on related market reports and key industry topics.